AXAxinet
Menu
Finance

Live market screen

Commercial Space Company Risk / Opportunity Ranking

Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.

Updated June 27, 2026

Companies analyzed
438
Ranked rows
876
Evidence links
356
Rows per page
20

Opportunity view

Showing rows 341-360 of 438; 20 rows per page.

Sorted by raw opportunity score
RankCompanyScoreThesis / Evidence
341
NeevCloud
lowweak
Opp 1
Risk 1

Thesis: No positive thesis is supportable because no direct positive evidence survived the 90-day recent evidence window in the retained reviewed sources.

Why now: Why now is weak: despite membership rationale referring to partnerships and orbital data center / AI inferencing context, the retained reviewed sources contain zero evidence after recent evidence window and no citable article summaries.

Caveats: Phase-2 membership rationale references, and: but no summaries or direct evidence are retained here for factual claims. The reviewed sources itself says NeevCloud is space-adjacent and not clearly a qualifying space company.

342
Neo Space Group
lowweak
Opp 1
Risk 2

Thesis: Potential opportunity exists if Neo Space Group is a meaningful customer or distribution node for satellite imagery supply to the Saudi government, but the reviewed sources does not provide available direct evidence within the recent evidence window to assess durability or monetization.

Why now: No validated near-term or durable timing signal is available in the available evidence. Recency is uncertain because zero after-recent evidence window evidence were available.

Caveats: Phase-2 rationale references, but no or summary is provided in the reviewed sources. Counterparty context should not be treated as propagated evidence for Neo Space Group's own thesis. Coverage debug shows zero evidence after recent evidence window.

343
NewOrbit
lowweak
Opp 1
Risk 1

Thesis: Reviewed evidence rationale says NewOrbit raised a £13.8 million Series A and is building VLEO sovereign communications satellites, but no retained evidence are present here to support a stronger ranked opportunity.

Why now: No retained post-recent evidence window evidence are available, so current timing cannot be established from these reviewed sources.

Caveats: Only membership rationale supports the company in this screen. No citeable retained evidence after recent evidence window.

344
OHB SE
lowweak
Opp 1
Risk 1

Thesis: No within the recent evidence window direct positive evidence was available, so there is insufficient reviewed sources support to form a positive 1 year+ opportunity thesis.

Why now: There is no retained article or evidence row after the 90-day recent evidence window for OHB SE; recency-based ranking is therefore not supported by the reviewed sources.

Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Phase-2 cohort membership rationale is not directional evidence and cannot substitute for retained article evidence. Because no article were retained after recent evidence window, no company-specific factual thesis can be cited from these reviewed sources.

345
Optimized Electrotech Pvt Ltd
lowweak
Opp 1
Risk 1

Thesis: The membership rationale suggests funding and expansion into space-based sensing with initial satellite platform orders, but the reviewed sources provide no retained within the recent evidence window article evidence or to support a positive thesis.

Why now: No retained company evidence after the 90-day recent evidence window means there is no evidence-set-backed timing reason to rank this name higher now.

Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale cites article IDs, and, but no or retained evidence text are available here. Without retained article evidence, absence of bad news is not positive evidence.

346
Orbex
mediumweak
Opp 1
Risk 5

Thesis: Orbex has only minimal current opportunity evidence in these reviewed sources because the cited article context about its Prime microlauncher predates the 90-day recent evidence window and therefore should not be relied on as current support.

Why now: The only surfaced article is dated February 17, 2026, outside the reviewed sources cutoff date of March 29, 2026, and the evidence recent evidence review says both rows were dropped; the article summary said Orbex released new photographs of its microlauncher Prime 'as the company looks to secure a future'. Because this is outside recent evidence window, recency support is absent.

Evidence
  • Article summary said Orbex released photographs of Prime as the company looks to secure a future, but it is dated February 17, 2026 and was dropped by the 90-day recent evidence window. space.n2k.com

Caveats: Primary surfaced evidence is outside recent evidence window and should not be treated as current proof. No in-recent evidence window direct positive or negative evidence is available.

347
OrbitOn
lowweak
Opp 1
Risk 1

Thesis: OrbitOn appears in an external SpaceFund satellite-servicing listing as 'Developing an on-orbit satellite servicing solution,' which is relevant product context, but the article is dated March 4, 2025 and was dropped by the 90-day recent evidence window, so it cannot support a current scored opportunity thesis in these reviewed sources

Why now: Why now is weak because the only visible article has March 4, 2025 on a source date basis and the reviewed sources report no current evidence was retained after the March 29, 2026 cutoff

Evidence
  • External listing describes OrbitOn as 'Developing an on-orbit satellite servicing solution,' but the reviewed sources say this evidence was outside the 90-day recent evidence window and therefore not kept for current ranking use. spacefund.com

Caveats: Only article detail shown is outside the 90-day recent evidence window and was dropped. Database/listing style evidence is weaker than company-specific event evidence. External supporting source context is relevance context, not stronger than direct retained evidence.

348
Palantir Technologies
lowweak
Opp 1
Risk 2

Thesis: This reviewed sources does not provide citable reviewed evidence to support an opportunity thesis for Palantir despite a membership rationale mentioning possible participation in a U.S. Space Force Golden Dome context.

Why now: Why now is weak because the reviewed sources references article IDs, and in the membership rationale, but no or reviewed evidence are provided for ranking use.

Caveats: High mention count is not conviction. Cohort relevance via Space Force context is not enough without direct event/fact evidence. Coverage debug shows zero evidence after recent evidence window despite large article universe.

349
Paras Defence and Space Technologies Ltd
lowweak
Opp 1
Risk 1

Thesis: No positive thesis is supported within the reviewed sources' 90-day evidence window. The only cited reviewed sources rationale is older context that the company incorporated a semiconductor subsidiary, but no within the recent evidence window direct positive evidence is available in these reviewed sources.

Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Paras Defence and Space Technologies Ltd.

Caveats: Phase-2 membership rationale references article, but the reviewed sources does not provide or quoted evidence for that item, so it cannot be used as a factual directional citation. No direct positive or negative evidence survived the 90-day recent evidence window.

350
Parsons Corporation
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources only provides older membership context that Parsons has 'space' among technology areas and appears in an SSA market report, but no within the recent evidence window direct positive evidence is available, so no positive thesis is supportable here.

Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Parsons Corporation.

Caveats: Phase-2 membership rationale references articles: and, but the reviewed sources provide no for citation. Article-level market-report inclusion is weaker than direct company-specific operating evidence.

351
PhysicsX
lowweak
Opp 1
Risk 1

Thesis: Phase-2 rationale says PhysicsX raised $300M, but the reviewed sources characterizes the source as a broad tech funding roundup and provides no retained direct positive evidence inside the 90-day window, so the opportunity case is not currently evidenced.

Why now: There is no current catalyst evidence because articles after recent evidence window = 0 and evidence after recent evidence window = 0.

Caveats: Funding-round context in rationale lacks -cited retained evidence here. Space relevance is explicitly weak in the reviewed sources rationale.

352
PierSight
lowweak
Opp 1
Risk 1

Thesis: Insufficient admissible reviewed sources evidence to support a positive thesis within the selected recent evidence window, despite membership rationale describing PierSight as building the Varuna 2.0 SAR and AIS maritime-monitoring satellite.

Why now: Why now is unsupported because the reviewed sources show no surviving evidence after recent evidence filtering; there is no direct dated milestone or problem signal to anchor a 1 year+ thesis.

Caveats: Only membership-level rationale is present; no citable evidence survived. No direct company-specific positive or negative events are available in the reviewed sources. Low scores reflect evidence scarcity.

353
Pixxel
lowweak
Opp 1
Risk 1

Thesis: The earlier Pixxel reviewed sources version suggests Earth-observation and fundraising relevance in membership rationale, but there are no retained within the recent evidence window evidence or article summaries to support a current opportunity thesis.

Why now: Why now is weak because no articles or evidence were retained after the March 29, 2026 cutoff in these reviewed sources version.

Caveats: Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Membership rationale references article IDs without, which cannot be cited as factual support here.

354
Portal Space Systems
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources' rationale mentions a $50 million Series A and maneuverable spacecraft technology, but no retained within the recent evidence window article evidence is present here to substantiate a positive thesis.

Why now: There is no retained evidence inside the 90-day recent evidence window, so no current catalyst or business-state update is citable from these reviewed sources.

Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale references article IDs, and, but no or retained summaries are supplied. Low score reflects lack of citable evidence, not a negative business judgment.

355
Precursor SPC
lowweak
Opp 1
Risk 1

Thesis: No positive thesis is supportable from retained evidence. The phase-2 rationale says Precursor SPC uses Spire data for hypersonic tracking and an AI/ML ionospheric nowcasting system tied to article, but the reviewed sources provide no representative article details, quote, or and no retained evidence after recent evidence window.

Why now: Why now is weak because the reviewed sources show no available post-recent evidence window evidence; evidence recent evidence review kept_rows is 0 and coverage data articles after recent evidence window is 0.

Caveats: Phase-2 rationale references without or retained evidence detail, so it is not sufficient for factual grounding here. No direct positive or negative evidence arrays are populated. Low scores are an evidence-gap judgment, not a business conclusion.

356
Quantum Opus
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources references older membership support that Quantum Opus helped build a lunar-Earth laser communication terminal used on Artemis II via article, but there is no retained in-window direct positive evidence with to support a current opportunity thesis.

Why now: There is no clear why-now catalyst because coverage after the 90-day recent evidence window is empty.

Caveats: Membership support exists but no representative article is provided for. No retained evidence after recent evidence window. No direct business-state update, financing, contract, or customer traction evidence is available.

357
Quantum Systems GmbH
lowweak
Opp 1
Risk 1

Thesis: No direct positive evidence is available. The reviewed sources say Quantum Systems is mentioned only via founders investing in another startup and as a portfolio-company reference, which is not sufficient for a positive company thesis.

Why now: There is no supported near-term or long-horizon catalyst in the reviewed sources because zero post-recent evidence window evidence were available.

Caveats: Phase2 rationale references article IDs: and: as article context only, but no were provided in the reviewed sources. Coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Context-only mentions and portfolio references cannot substitute for direct positive or negative evidence.

358
Relativity Space
lowweak
Opp 1
Risk 2

Thesis: Relativity Space has a plausible long-horizon opportunity narrative as a rocket developer with financing context in membership rationale, but the reviewed sources contain no retained evidence within the recent evidence window to support a current opportunity call.

Why now: Why now is weak because there are no retained post-cutoff article summaries or evidence in the reviewed sources.

Caveats: No retained evidence after recent evidence window. The modest risk uplift reflects uncertainty from lack of current confirmation, not a direct adverse event.

359
Rocket Factory Augsburg
lowweak
Opp 1
Risk 2

Thesis: The membership rationale mentions focus on a first test launch later in the summer, which could be strategically important, but there is no retained evidence row to support a scored positive thesis.

Why now: No retained article or event evidence remains after recent evidence filtering; the only hint is a membership rationale referencing first test-launch focus via article: without an included summary.

Caveats: Cannot treat membership rationale alone as strong directional proof. No article summary or retained evidence row is included for article

360
Rogers Communications Inc.
lowweak
Opp 1
Risk 1

Thesis: Only a very weak opportunity read is possible: the reviewed sources rationale says Rogers was mentioned as a Starlink telco partner in a SpaceX IPO article, implying possible exposure to direct-to-device or satellite connectivity, but no in-recent evidence window company evidence or citable article summary were available for Rogers in these reviewed sources.

Why now: There is no available 90-day evidence for Rogers in these reviewed sources; coverage data shows zero article ids after recent evidence window and zero evidence after recent evidence window, so there is no supported 'why now' catalyst in the provided evidence.

Caveats: No direct positive or negative evidence were available after the 90-day recent evidence window for Rogers. Phase2 rationale references support references including: but no article or article summary for that item is included in these reviewed sources, so it cannot be cited as factual evidence. Opportunity score is kept near zero because the evidence standard require positive evidence, not mere absence of risk.

Risk view

Showing rows 1-20 of 438; 20 rows per page.

Sorted by raw risk score
RankCompanyScoreThesis / Evidence
1
Blue Origin
mediummedium
Opp 6
Risk 7

Thesis: Execution risk is elevated because the same recent evidence set documents a New Glenn launchpad explosion on May 28, 2026, creating material uncertainty around launch reliability and schedule even though government customers reaffirmed support.

Why now: The setup is active and recent: on May 30, 2026 SpaceNews reported Blue Origin received an NSSL task order hours before a New Glenn explosion, while on May 27, 2026 GeekWire reported New Glenn was preparing to return to service for an Amazon Leo mission after its first launch failure; on May 26, 2026 Investing.com summarized a NASA moon-base contract with launch no earlier than fall 2026

Evidence
  • Published May 30, 2026: SpaceNews reported the task order came hours before a New Glenn launch vehicle exploded during a hot fire test at Cape Canaveral on May 28. spacenews.com
  • Published May 27, 2026: GeekWire said Blue Origin was returning New Glenn to service five weeks after its first launch failure. geekwire.com
  • Published May 30, 2026: Space Force awarded Blue Origin a National Security Space Launch Phase 3 Lane 1 task order for an NRO mission. spacenews.com

Caveats: Positive evidence is mostly supporting article context rather than direct events. One external article is undated and is not relied on for recency proof. Government support after the anomaly partially offsets, but does not erase, execution risk.

2
Katalyst Space Technologies
highstrong
Opp 8
Risk 6

Thesis: Risk is also elevated because the mission profile is technically ambitious and schedule-sensitive: the rescue concept is framed as potentially the first time a commercial robotic spacecraft docks with an unprepared government satellite, and the telescope is described as at risk of deorbit by late 2026, implying high execution stakes.

Why now: Why now is strong because the latest dated evidence on June 23, 2026 adds new capital after the May 29, 2026 NASA-related mission context, supporting a 1 year+ thesis that the company is moving from concept credibility toward funded development in on-orbit servicing.

Evidence
  • The Swift Observatory is described as at risk of uncontrolled deorbit by late 2026, and the mission would require a first-of-its-kind commercial robotic docking with an unprepared government satellite, implying substantial execution risk. katalystspace.com
  • Katalyst announced a NASA Phase III SBIR contract to develop a concept for a responsive rendezvous mission to save the Neil Gehrels Swift Observatory, with a proposed rescue mission that would raise its orbit and extend operational life. katalystspace.com
  • On June 23, 2026, Katalyst announced it raised $12 million to develop its NEXUS robotic spacecraft and expand satellite servicing across multi-orbit and multi-mission operations. pulse2.com

Caveats: Part of the positive case comes from company-issued materials and supporting article context rather than independent positive evidence. The May 29, 2026 article includes a dated source date but describes an announcement text beginning 'August 11, 2025'; chronology should therefore be read carefully, with the treated as the recency marker for this retrieved item. Citation

3
Anduril Industries
mediummedium
Opp 7
Risk 5

Thesis: Risk remains elevated because the reviewed sources' evidence is mostly supporting article context rather than company-specific positive evidence, and program participation does not confirm revenue realization, production conversion, or margin outcomes. The capital raise also implies a company still in heavy scale-up mode rather than de-risked execution.

Why now: The timing is supported by recent 2026 article context around Space Force Andromeda participation and the June 19, 2026 financing context, which together suggest active momentum over the last quarter.

Evidence
  • Published April 8, 2026: U.S. Space Force SSC awarded 14 companies more than $1.8B in firm fixed price Andromeda contracts for RG-XX satellites; the companies include Anduril Industries. defensedaily.com
  • Published June 19, 2026: Anduril Industries raised a $5B Series H round, bringing total funding to $11B. spaceambition.substack.com

Caveats: Most evidence is weak context-only article evidence, not direct positive events in the available ranking rows.

4
AST SpaceMobile, Inc.
highstrong
Opp 8
Risk 5

Thesis: Risk remains elevated because the thesis still depends on large-scale deployment and commercialization execution; the reviewed sources show authorization and partnerships, but limited direct proof of broad revenue conversion or completed network rollout inside the recent evidence window.

Why now: The key timing event is the FCC authorization dated April 21, 2026/April 22, 2026 granting authority for up to 248 satellites and direct-to-device service, a milestone that can unlock U.S. commercial and government use cases over a 1 year+ horizon. Later-dated company-site context on June 23, 2026 also says AST has nearly 60 operator partners and targets direct broadband to standard smartphones.

Evidence
  • Published April 21, 2026: FCC granted AST SpaceMobile authority to launch and operate a 248-satellite constellation and provide direct-to-cell service. satnews.com
  • Published April 22, 2026: company said FCC commercial authority enables operation of up to 248 satellites to deliver supplemental coverage from space directly to unmodified mobile devices. businesswire.com
  • Published March 3, 2026: TELUS signed a commercial agreement with AST and would invest in ground infrastructure and become an equity shareholder. businesswire.com

Caveats: Much of the evidence is company, press-release, or article-context based rather than independent hard performance metrics. The reviewed sources cites a target of 45 to 60 BlueBird satellites by end-2026 in article summary context, but this is not available as a direct structured fact here.

5
Atomic-6
lowweak
Opp 4
Risk 5

Thesis: Risk is moderate because none of the underlying article summaries or are provided in the visible evidence section, so the apparent positives cannot be independently grounded from the reviewed sources output beyond the rationale text.

Why now: The reviewed sources rationale cites article and says Atomic-6 launched an orbital data center service and has DoD and U.S. Space Force contracts, but no representative article or is provided in the visible reviewed sources, so timing confidence is limited.

Caveats: No direct evidence or article are available in the reviewed sources body. Opportunity thesis relies on membership rationale rather than citable article summary. Because the underlying evidence is not exposed, conviction must stay low.

6
Intuitive Machines, Inc.
mediummedium
Opp 6
Risk 5

Thesis: Risk is also moderate because the evidence is lighter than for top-ranked names and the key contract appears to be an IDIQ selection/competition vehicle rather than a clearly quantified standalone revenue award in the reviewed sources.

Why now: The timing case comes from May 12, 2026 reporting that Intuitive Machines was selected for the Space Force Andromeda IDIQ to develop space surveillance capabilities through 2030 and beyond, described as the company's first major selection following the Lanteris Space acquisition.

Evidence
  • Published May 12, 2026: Intuitive Machines said it was selected by the U.S. Space Force for the Andromeda IDIQ contract to develop space surveillance capabilities. investing.com
  • Published April 8, 2026: Defense Daily summarized that Space Force awarded 14 companies more than $1.8 billion in Andromeda contracts, and the company list includes Intuitive Machines. defensedaily.com

Caveats: The reviewed sources provide supporting article context but no direct structured fact with quantified contract value specific to Intuitive Machines. No direct adverse evidence is available; risk is based on competitive award structure and evidence limitations. Long-horizon upside depends on conversion from selection status into meaningful programs.

7
Momentus
mediummedium
Opp 7
Risk 5

Thesis: Risk remains elevated because the evidence set emphasizes announcements and pipeline/contract positioning rather than broad proof of scaled recurring commercial adoption; some supportive contract context, including SHIELD selection, is older than the recent evidence window and should not be over-weighted for recency.

Why now: Why-now is supported by recent mission and contract evidence within the recent evidence window: on March 30, 2026 Momentus announced the successful launch of Vigoride 7 and called it its most advanced on-orbit demonstration campaign to date; on June 17, 2026 it announced a new commercial contract with LASP to host and operate the OWLS mission on Vigoride-9, expanding its commercial revenue portfolio.

Evidence
  • Momentus announced the successful launch of its Vigoride 7 Orbital Service Vehicle, calling it a major milestone and the start of its most advanced on-orbit demonstration campaign to date. businesswire.com
  • Momentus said it secured a new commercial contract with the University of Colorado Boulder’s LASP to host and operate the OWLS mission on the Vigoride-9 Orbital Service Vehicle, further expanding its commercial revenue portfolio. businesswire.com

Caveats: The SHIELD contract-vehicle selection is dated December 10, 2025 and outside the 90-day recent evidence window, so it is useful background but not a recency catalyst here. Some weak context rows repeat the same article-level claims and are not independent confirmation.

8
Momentus Inc
lowweak
Opp 4
Risk 5

Thesis: Momentus receives the highest risk score in the thin-evidence group because the reviewed sources references a commercial contract but provides no current available corroboration, leaving substantial uncertainty around execution, financing durability, and contract conversion. This is still an evidence-gap risk, not a confirmed adverse-event thesis, because no direct negative evidence is available (: and: unavailable in reviewed sources).

Why now: Why now is medium because an orbital services contract can matter over a 1 year+ horizon, but the reviewed sources' post-recent evidence window evidentiary absence prevents stronger timing confidence.

Caveats: No direct evidence remained after the recent evidence filter.

9
Orbex
mediumweak
Opp 1
Risk 5

Thesis: Risk is moderate because the only described usable context says the company was looking to secure its future, while all dated evidence shown is outside the allowed recent evidence window, leaving the current business state uncertain.

Why now: The only surfaced article is dated February 17, 2026, outside the reviewed sources cutoff date of March 29, 2026, and the evidence recent evidence review says both rows were dropped; the article summary said Orbex released new photographs of its microlauncher Prime 'as the company looks to secure a future'. Because this is outside recent evidence window, recency support is absent.

Evidence
  • Article summary said Orbex released photographs of Prime as the company looks to secure a future, but it is dated February 17, 2026 and was dropped by the 90-day recent evidence window. space.n2k.com

Caveats: Primary surfaced evidence is outside recent evidence window and should not be treated as current proof. No in-recent evidence window direct positive or negative evidence is available.

10
Orbital Inc.
mediummedium
Opp 6
Risk 5

Thesis: Risk is moderate because the reviewed sources provide only supporting article context and no direct evidence of contracts, deployment milestones, customer traction, or technical validation beyond the funding/context claim.

Why now: The usable evidence is recent within the 90-day recent evidence window: an April 14, 2026 article said Orbital got funded by Andreessen Horowitz to verify its space-based data center concept, which is relevant to a 1 year+ horizon because financing can support technology proof and strategic positioning

Evidence
  • AI satellite constellation startup Orbital gets funded by a16z to verify space-based data center concept. siliconangle.com

Caveats: Evidence is supporting article context/weak context rather than direct positive events. No reviewed sources evidence of customers, revenue, launch schedule, or technical milestone completion. Same article appears in multiple weak-context rows and should not be treated as independent confirmation.

11
Quantum Space
mediummedium
Opp 8
Risk 5

Thesis: The company still carries meaningful execution and transaction risk because the SPAC deal is only expected to close in the fourth quarter rather than already complete, contract value was undisclosed, and key program delivery is pushed out to 2028, leaving room for financing, closing, and execution slippage.

Why now: The evidence is recent and sequenced: on June 8, 2026 Quantum Space announced its planned SPAC merger and expected Nasdaq listing under QSPC

Evidence
  • Published June 8, 2026: the SPAC merger is expected to close in the fourth quarter, implying completion risk remains; access to the full trust depends on shareholder redemptions. spacenews.com
  • Published June 18, 2026: contract value was not disclosed and the company expects to deliver the vehicle by 2028, creating long-dated execution risk. spacenews.com
  • Published June 8, 2026: Quantum Space announced it will merge with Inflection Point Acquisition Corp. VI, expects the deal to close in the fourth quarter, and says the deal includes a $300 million PIPE plus $253 million in SPAC trust assuming no redemptions. spacenews.com

Caveats: Most available evidence is external overlay context rather than first-party positive or negative events. Same-theme repetition across June articles is not independent confirmation. Ticker QSPC is prospective after the expected SPAC close per June 8, 2026 evidence, not confirmed as already trading under that symbol

12
Sateliot
mediummedium
Opp 7
Risk 5

Thesis: Risk remains material because later evidence indicates the Series C is being sought rather than fully closed and that Sateliot is still seeking a lead investor, with up to 50% public co-financing hoped to match private investment. That means financing completion and constellation deployment remain execution-sensitive.

Why now: The sequence matters: the company launched the Series C on April 8, 2026/April 13, 2026, then later reporting on May 21, 2026 noted a first commercial launch contract, and June 24, 2026 reporting still described the round as seeking capital and a lead investor. That mix creates both opportunity and financing risk over a 1 year+ horizon.

Evidence
  • Published June 24, 2026, this says Sateliot is looking to raise new equity funding, is currently seeking to attract a lead investor, and anticipates up to 50 percent public co-financing. datacenterdynamics.com
  • TelecomTV says Sateliot is seeking €100 million in Series C funding and is looking to bring in a lead investor, indicating financing is still in process. Published April 13, 2026. telecomtv.com
  • Company-linked fact says Sateliot launched a €100 million Series C round to deploy 16 satellites for 5G IoT and direct-to-device connectivity. Published April 13, 2026. computerweekly.com

Caveats: The reviewed sources does not provide a direct positive event row for the first commercial contract; that support is supporting article context and weaker than a structured company event row. Later dated coverage indicates financing is still being sought, which partially offsets the opportunity thesis. Undated context items exist in the reviewed sources but are not used for recency-sensitive judgments.

13
Spark Space
mediummedium
Opp 5
Risk 5

Thesis: Risk is equally meaningful because the evidence is undated supporting article context, so recency is uncertain and there is no direct evidence of launch contracts, orbital milestones, or sustained financing beyond the article summary.

Why now: The reviewed sources retains undated evidence indicating Spark Space tested its engine and raised funds for an electric-pump rocket, but the article has no publication timestamp, so recency-sensitive claims should be treated cautiously.

Evidence
  • Chinese startup developing electric-pump rocket; raised funds and tested engine. spacenews.com

Caveats: Article is undated, so business-state recency is uncertain. Evidence is supporting article context, not direct dated event/facts. Same article appears twice in weak-context rows and is not independent confirmation.

14
Turion Space
mediummedium
Opp 7
Risk 5

Thesis: Risk remains meaningful because the evidence still describes an early-stage company scaling from a small launched base into a persistent constellation and potentially adjacent on-orbit services, which implies execution and capital deployment risk; however, the reviewed sources contain no direct adverse event evidence.

Why now: The key timing driver is the dated financing round on April 15, 2026, which the reviewed sources say positions the company to scale beyond single-mission spacecraft toward a persistent SDA constellation, a development relevant over a 1 year+ horizon.

Evidence
  • Turion Space closed a $75 million Series B round on April 15, 2026, to accelerate deployment of its space domain awareness satellite fleet; total capital raised is approximately $115 million. orbital-intel.com
  • Turion Space said it has raised more than $75 million in a Series B round; it develops satellites and payloads focused on space domain awareness and had launched two spacecraft, with Droid.002 deployed in March. spacenews.com

Caveats: The reviewed sources have no direct positive or negative dated events; the case relies on supporting article context rather than stronger internal company-specific events. The company website context on May 23, 2026 is weaker than independent company-specific event evidence and should not be overweighted. Citation

15
Volta Space Technologies
lowweak
Opp 4
Risk 5

Thesis: Risk is moderate to elevated because the cited milestone is far out, execution risk is likely high, and the reviewed sources exposes no direct article summary or to confirm near-term de-risking.

Why now: The rationale cites article and says the company has a 2028 demonstration planned with payload booked on Blue Ghost Mission 2, which is relevant to a 1 year+ strategic horizon but weak for immediate evidence-based ranking because no article body or is visible.

Caveats: No visible representative article, quote, or in the reviewed sources body. The main cited demonstration is scheduled for 2028, so commercial payoff may sit beyond the stated 1 year+ ranking horizon. The Firefly payload linkage cannot be used as counterparty propagation evidence beyond the explicit rationale.

16
Albedo
lowweak
Opp 4
Risk 4

Thesis: Risk is also meaningful because this evidence is supporting article context only, not direct event/fact evidence in the reviewed sources' stronger fields, and the article describes Albedo as a former Earth-observation startup now focused on satellite manufacturing, implying strategic transition/execution uncertainty

Why now: Why now is stronger than for most names because the reviewed sources includes a dated representative article with April 9, 2026, stating that on April 9 Albedo announced plans for its second spacecraft and a 2027 launch for its second VLEO mission

Evidence
  • Representative article summary: Albedo announced plans April 9 to send its second spacecraft; summary says the company prepares a second VLEO mission for 2027 launch. spacenews.com

Caveats: The reviewed sources marks this as weak context only / supporting article context, not strong direct event evidence. Same article appears in multiple weak-context rows and should not be treated as independent confirmation.

17
Apex Space
mediummedium
Opp 8
Risk 4

Thesis: Risk is moderate, not because of explicit adverse evidence, but because the strongest structured support is neutral fact/context rather than explicit positive events in the reviewed sources. The evidence leans heavily on company/external article context and financing narratives, so execution risk around scaling manufacturing and converting strategic positioning into durable contracts remains an offset.

Why now: Why now is strong because the key financing evidence is dated June 5, 2026 and the Northrop partnership article is dated June 1, 2026, making both recent within the 90-day recent evidence window and relevant to a 1 year+ scaling thesis. The June 5 financing event is later than the April 16 capacity/context article and therefore better reflects current business state.

Evidence
  • Apex raised over $200 million at a $2.3 billion valuation to scale satellite bus production for proliferated constellations. Published June 5, 2026. apexspace.com
  • Corroborating dated fact: Apex raised over $200 million at a $2.3 billion valuation to scale satellite bus production for proliferated constellations. Published June 5, 2026. payloadspace.com
  • Article says Northrop Grumman partnered with Apex to develop space-based interceptors for the Golden Dome missile defense program; June 1, 2026. spacenews.com

Caveats: Most available evidence is neutral fact or supporting article context, not explicit positive events. Same-day repeated articles around the fundraise are not independent proof beyond corroboration. Some context sources are company-issued or article-level summaries, which are weaker than direct events.

18
Astrobase Space Technologies
mediummedium
Opp 6
Risk 4

Thesis: Risk remains material because the visible evidence is supporting article context around funding and ambition rather than proof of technical milestone completion, customer adoption, or flight success. Deep-tech engine development inherently depends on execution, but the reviewed sources does not document adverse events.

Why now: The funding article is recent, with published June 12, 2026, and specifically notes this as IN-SPACe's first investment in Indian startups under the TAF scheme. That timing matters for a 1 year+ horizon because it may enable development progress over coming quarters.

Evidence
  • Published June 12, 2026: IN-SPACe selected Astrobase Space Technologies under its Technology Adoption Fund; selected startups 'will each receive a maximum of ₹25 crore' and Astrobase aims to develop a 'high-thrust closed-cycle liquid rocket engine.' startup.economictimes.indiatimes.com

Caveats: Visible evidence is only one external article summary despite the membership rationale referencing multiple structured support articles. No technical test results or customer contracts are provided in the exposed evidence.

19
Astroscale
mediummedium
Opp 7
Risk 4

Thesis: The reviewed sources also indicates Astroscale is still transitioning from technology demonstrations into repeatable commercial work, and its May 2026 financing cites an uncertain market environment, so scaling and capital-market dependence remain meaningful risks.

Why now: Recency is the main reason: on June 22, 2026 SpaceNews said Astroscale was 'working to transition from technology demonstrations to a regular series of missions, bolstered by a recent capital infusion' and saw 'repeatable business opportunities' particularly among defense customers. On May 19, 2026 financing materials said the company would raise 30.6 billion yen to secure medium-to-long-term growth funding 'in anticipation of transitioning to a phase of continuous order acquisition'. On April 6, 2026 Astroscale revealed its ISSA-J1 mission scheduled for launch in 2027.

Evidence
  • Published June 22, 2026: the company is still transitioning from demonstration missions to regular commercial missions, implying execution risk before repeatability is proven. spacenews.com
  • Published May 19, 2026: financing materials reference raising capital amid an 'uncertain market environment,' indicating ongoing funding and market-condition sensitivity. finance.biggo.com
  • Published June 22, 2026: Astroscale is 'working to transition from technology demonstrations to a regular series of missions, bolstered by a recent capital infusion' with prospects for 'repeatable business opportunities,' particularly among defense customers. spacenews.com

Caveats: Most within the recent evidence window evidence is supporting article context, not structured company-specific events; reviewed sources warns supporting article context is weaker than direct event/fact evidence. Same-article repeated weak-context rows are not independent confirmation. Older 2023 and 2025 articles exist in representative articles but fall outside the 90-day recent evidence window for ranking use.

20
BlackSky Technology Inc.
highstrong
Opp 8
Risk 4

Thesis: Risk is still moderate because the $99 million item is an IDIQ ceiling with only initial funding disclosed, and much of the reviewed sources support is article-context level rather than dated events; execution on next-generation payload design and constellation roadmap still matters.

Why now: The why-now is supported by two dated recent wins inside the recent evidence window: on March 31, 2026 BlackSky said it received a multi-year sole-source $99 million U.S. government IDIQ and initial $2 million funding for advanced large-aperture payload design; on April 22, 2026 it announced a competitive $25 million multi-year assured contract with a major international defense customer and said it had four Gen-3 satellites on orbit and was rapidly deploying Gen-3 capacity while driving up backlog and annual recurring revenue.

Evidence
  • BlackSky was awarded a multi-year, sole-source $99 million U.S. government IDIQ contract and received an initial $2 million to accelerate design of an advanced large aperture optical payload for Earth observation and space domain awareness platforms. businesswire.com
  • BlackSky won a competitive $25 million, multi-year Assured contract with a major international defense customer; the company said four Gen-3 satellites are on orbit and it is rapidly deploying Gen-3 capacity while driving up backlog and annual recurring revenue. ir.blacksky.com

Caveats: The $99 million figure is an IDIQ ceiling, not fully funded revenue at announcement; only an initial $2 million was specifically disclosed. Some corroboration repeats the same underlying announcement and should not be treated as independent evidence